Fox, who majored in chemistry at Bryn Mawr before going on to earn a Ph.D. at the Massachusetts Institute of Technology, holds a number of patents. “With three drugs that have moved from the lab to clinical trials, and a fourth on the way later this year,” says Mass High Tech, she is “making a difference in the world.”
Fox served on the faculty of the University of Maryland School of Medicine before becoming vice president of immunology at ImmuLogic Pharmaceutical Corp. In 1998, she founded Recovery Pharmaceuticals, a company that dealt in medications for the treatment of addiction.
Avaxia, Fox’s current project, is developing orally administered antibody therapies for gastrointestinal diseases such as inflammatory bowel disease and celiac disease.
Mass High Tech‘s Women to Watch awards recognize “women in tech and life sciences who are thought leaders in their field and shaping the future of their industries for years to come.”